Skip to main content

4 Result(s)

within Stefania Millepiedi Remove this filter Neurosciences Remove this filter Pharmacotherapy Remove this filter

and

  1. No Access

    Article

    Aripiprazole Monotherapy in Children and Young Adolescents with Pervasive Developmental Disorders

    Background: Pervasive developmental disorders (PDDs) are severe psychiatric disorders characterized by impairment in social interactions, in verbal and non-verbal communication, and by restricted...

    Gabriele Masi, Angela Cosenza, Stefania Millepiedi, Filippo Muratori… in CNS Drugs (2009)

  2. No Access

    Article

    Pharmacotherapy in Paediatric Obsessive-Compulsive Disorder

    Background: Pediatric obsessive-compulsive disorder (OCD) can cause substantial impairment in academic, social and family functioning. Even though cognitive-behavioural therapy (CBT) is an effect...

    Dr Gabriele Masi, Stefania Millepiedi, Giulio Perugi, Chiara Pfanner… in CNS Drugs (2009)

  3. No Access

    Article

    Effectiveness of Lithium in Children and Adolescents with Conduct Disorder

    Background: The most severe forms of conduct disorder (CD) are disabling conditions, often resistant to treatment and likely to evolve into antisocial behaviours. Mood stabilizers and atypical antipsychotics are ...

    Dr Gabriele Masi, Annarita Milone, Azzurra Manfredi, Cinzia Pari… in CNS Drugs (2009)

  4. No Access

    Article

    Separation Anxiety Disorder in Children and Adolescents

    This paper provides an overview of the phenomenology, longitudinal outcome data, assessment and management of separation anxiety disorder (SAD) in children and adolescents.

    Dr Gabriele Masi, Maria Mucci, Stefania Millepiedi in CNS Drugs (2001)